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The Burden of Diabetes and Use of Diabetes Care in Humanitarian Crises in Low- and 
Middle-Income Countries 
ABSTRACT 
Human suffering arising out of disaster or conflict includes death and disability from non-
communicable diseases, including diabetes, which have largely been neglected in humanitarian 
crises. The objectives of this paper were to examine the evidence on the burden of diabetes, 
utilization of health services, and access to care for people with diabetes among populations 
affected by humanitarian crises in low- and middle-income countries and identify research gaps 
for future studies We performed a review of the literature on this topic published between 1992 
and 2018. The results highlight that the burden of diabetes in humanitarian settings is not being 
captured, clinical guidance is lacking, and suggest diabetes is not being adequately addressed. 
Crisis-affected populations with diabetes face enormous constraints in accessing care, primarily 
due to high medical costs. Further research is needed to characterize the epidemiology of diabetes 
in humanitarian settings and develop simplified, cost-effective models of care to improve the 
delivery of diabetes care in the wake of global disasters.  
INTRODUCTION 
As a result of humanitarian crises, forced migration due to conflict has reached a record number 
with 68.5 million people forcibly displaced from their homes by the end of 2017.4 Of these, 25.4 
million refugees have fled across international borders and approximately 40 million internally 
displaced persons (IDPs) have been forcibly displaced within their own country.5,6 There are also 
approximately 100 million people who are affected by conflict, but are not displaced.7 Natural 
disasters affect an estimated 175 million people annually.8 In addition, emergencies are 
increasingly becoming protracted with the average length of forced displacement being over 20 
years.6 Low- and middle-income countries (LMICs) host around 84% of forced migrants globally 
and commonly have very limited resources to respond to their health needs.6 LMICs also carry the 
largest burden of diabetes.  
Individuals with diabetes are particularly vulnerable in humanitarian crises, given disrupted health 
services and impeded food supplies due to insecurity and population movement.9 This risks 
exacerbating medical complications from diabetes, particularly for those with type 1 diabetes 
(T1D). In addition, crisis-affected populations are at risk of developing or exacerbating diabetes 
through elevated mental disorders and risky behaviours, such as harmful alcohol use. The 
increasing trend towards urbanisation of crisis-affected populations may also lead to 
environmental risk-factors related to diet, physical activity and tobacco use.10 Moreover, childhood 
malnutrition and exposure to maternal undernutrition in utero increase the risk of diabetes in 
adulthood.11,12  
The problem of diabetes and other non-communicable diseases (NCDs) has largely been neglected 
in humanitarian settings.9,13-15 Historically, the main causes of morbidity and mortality in 
humanitarian settings were infectious diseases and malnutrition, particularly among children.15 
Given global epidemiological changes and that LMICs are now commonly affected by crises 
(where the underlying burden of NCDs is high), humanitarian agencies and governments are 
challenged with how to effectively tackle diabetes and other NCDs.9 While there is a growing 
literature on the burden of NCDs in LMICs, including diabetes, it is unclear whether these studies 
can be generalised to humanitarian crisis. It is not known what the burden of diabetes is, which 
interventions are effective and feasible, and there is a lack of evidence-based guidelines and basic 
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diagnostic, clinical and preventive resources for the management of diabetes in humanitarian 
contexts.13,14 
This Series seeks to outline the evidence on the burden of diabetes among crisis-affected 
populations and capture contemporary challenges in the management of diabetes in humanitarian 
crises in LMICs. The aim of this first Series paper is to examine evidence on diabetes among crisis-
affected populations in LMICs and propose future research priorities. The specific objectives are 
to: (1) examine the evidence on the burden of diabetes among populations affected by humanitarian 
crises in LMICs and (2) describe the evidence on health service utilization and access to care for 
people with diabetes in these settings in order to identify main research gaps and propose priorities 
for future research. The search strategy and selection criteria for the review are summarized in 
Panel 1 and detailed in Online Annex 1. The second Series paper describes the concrete challenges 
of diabetes care delivery in humanitarian crises.16  
EXISTING EVIDENCE 
We identified evidence from forty-one eligible studies.17-57 All studies were published between 
1992 and 2018, with thirty-three published since 2011. Thirty-eight studies reported on 
populations affected by armed conflict,17-25,27-33,35,36,38-57 two reported on populations affected by 
natural disasters,34,37and one on all crisis types.26 Thirty-four studies were conducted in the 
protracted crisis phase (crisis duration greater than six months),17-25,27-33,35,39-48,50,52-57 three in the 
emergency response phase (immediate aftermath of the event up to six months),36,49,51 two in the 
early recovery phase (more stable period of rebuilding up to two years following the crisis),34,38 
and two reported on multiple crises phases.26,37 Twenty-five studies addressed refugee 
populations,17-21,25,26,29-31,33,35,39-43,47,48,50,52-55,57 five addressed IDPs,22,28,32,46,56 and eleven 
addressed non-displaced conflict-affected populations.23,24,27,34,36-38,44,45,49,51 The majority of 
studies were conducted in the WHO Eastern Mediterranean (N=30),17-24,28-33,39-44,46-48,50,52-57  
followed by Europe (N=6),25,27,36,45,49,51 Western Pacific (N=2),34,37 South-East Asia (N=1), Africa 
(N=1), and one covered refugees bound for the United States.26 Further details on the studies can 
be found in Table 1 and Online Annex 2. 
Burden of diabetes  
The evidence on the burden of diabetes among crisis-affected populations was extremely limited 
and the overall quality of the studies was poor. Diabetes was most commonly used as a single 
diagnosis and distinctions between T1D, type 2 (T2D), and gestational diabetes (GDM) were rarely 
made. Three studies focused exclusively on T1D,27,49,51 eight categorized patients into T1D and/or 
T2D,24,32,33,40,41,47,52,53 and two reported on women with GDM.21,35 Atypical forms of diabetes were 
not addressed.  Only eighteen studies17,18,20-23,25,28-31,33,45,46,50,52,55,56 assessed the burden of diabetes 
at the population level using probabilistic sampling (rather than health-facility level using non-
probabilistic sampling) and the majority of these relied on self-report rather than medical 
diagnosis. 
Diabetes prevalence rates varied substantially. Prevalence rates of diabetes in displaced Syrian 
populations during the crisis ranged from as low as 0.8% in Syria56 and Iraq53 to as high as 35% 
in certain governorates of Iraq.17 When examining older populations (age >60 years), diabetes 
prevalence rates ranged from 31.8% in Syria31 to 47% in Lebanon.55 An assessment on the 
healthcare needs of IDPs in Iraq reported a 2.8% prevalence of GDM.22 However, over half of the 
pregnant women interviewed had not received a single antenatal visit by their third trimester and 
therefore not been screened for GDM. 
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In Europe, two studies reported pre- and post-conflict incidence rates of insulin-dependent diabetes 
(IDDM) in Croatia using the national diabetes registry.49,51 One study reported the annual age-
adjusted incidence of IDDM in children (ages 0-15) in Zagreb of 7.0 in 1988 before the war and 
7.8 in 1992 after the war.49 The second study reported annual incidence rates of IDDM in Zagreb 
of 6.6 per 100,000 in 1988 and 5.9 per 100,000 in 1992.51 In the Tuzla region of Bosnia and 
Herzegovina, which was heavily affected by war, the incidence rate of NIDDM from 1990-1998 
was 3.03 per 100,000 person years.27 In Turkey, 4.1% of Syrian refugees self-reported a diagnosis 
of high blood sugar (was not further defined) in the past twelve months.25 
The only study conducted in South-East Asia reported the prevalence of GDM in a refugee camp 
at the Thai-Myanmar border, screening pregnant women with a 75mg oral glucose tolerance test 
(OGTT).35 Although the sample size was small and the number of all pregnant patients in the 
catchment area was not recorded, the estimated prevalence rate was 10.1% using HAPO trial cut-
off values.58 
In Africa, the only identified study was a retrospective study evaluating mortality patterns based 
on chart review at a hospital in Liberia.38 Two percent of deaths from January through July 2005 
were attributed to diabetes.  
Glycaemic control and diabetes complications 
Seven studies reported on glycaemic control,24,40,41,45,49,52,53 but how this was assessed varied and 
often relied on fingerstick glucose readings at different times of day, such as fasting or two hours 
post-prandial (2hPPG). Hemoglobin A1C (A1C) measures were reported in six 
studies.27,24,45,49,52,53  
An analysis of the national diabetes registry in Croatia during the war in 1991 reported an average 
fasting glucose of 194.4 mg/dl (10.8 mmol/l) in displaced persons (average A1C 9.8% (84 
mmol/mol)) and 183.6 mg/dl (10.2 mmol/l) in non-displaced persons (average A1C 9.1% (76 
mmol/mol)), which was not significantly different (p=0.38).49 In Bosnia and Herzegovina a study 
assessed the impact of three years of war on glycaemic control using hospital data from Sarajevo. 
Between 1992 and 1994/1995 there was a mean weight-loss of 11.7 kg with a reduction in mean 
fasting glucose from 207.0 mg/dl (11.5 mmol/l) pre-war to 176.4 mg/dl (9.7 mmol/l) post-war, and 
A1C reduction from 10.3% (89 mmol/mol) to 9.0% (75 mmol/mol) (p<0.01).45 This was 
accompanied by a reduction in blood pressure (BP) and hypoglycaemic medication use. 
In the Eastern Mediterranean, a cross-sectional study of Syrian refugees in a camp setting in Iraq 
reported an average A1C of 9.3% (78 mmol/mol) in individuals with T1D.53 Of these, 9.1% had 
A1C values <7.5% (58 mmol/mol) and 82% >8% (64 mmol/mol). Among those with T2D, the 
average A1C was 8.8% (73 mmol/mol), with 4.7% having an A1C <7.5% (58 mmol/mol) and 62% 
an A1C >8% (64 mmol/mol). Two studies by the United Nations Relief and Works Agency for 
Palestine Refugees (UNRWA) assessing Palestinian refugees in Jordan assessed glycaemic control 
via 2hPPG. In one study, 42% of those with diabetes attending the clinic had their post-prandial 
glucose measured.41 Of those, 50% had a 2hPPG of <180 mg/dl (10 mmol/l), which was considered 
good control. In the other study, done one year later, 99% of those attending the clinic had their 
post-prandial glucose measured, of which 65% had a reading <180 mg/dl (10 mmol/l).40 In Yemen, 
a significant increase in A1C from 7.7% (61 mmol/mol) to 9.4% (80 mmol/mol) was shown when 
comparing the same individuals before and during the war.24 
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Diabetes complications and surveillance were mentioned in five papers.33,40,41,52,53 In two studies 
by UNRWA in Jordan, the most common complications noted were myocardial infarction, 
congestive heart failure and stroke.40,41 Another study by UNRWA with Palestine refugees in 
Gaza, Jordan, Lebanon and the West Bank, reported the most common complications were 
peripheral neuropathy (52.6%), foot infections (17%), diabetic retinopathy (11%) and myocardial 
infarction (9.6%).  
Among Syrian refugees in a camp setting in Iraq, 63.6% of individuals with T1D self-reported 
having had episodes of symptomatic hypoglycemia, and 36.6% reported at least one episode of 
diabetic ketoacidosis.53 Among those with T2D, 24.3% reported having had at least one episode 
of hypoglycemia and 0.52% reported having had at least one episode of diabetic ketoacidosis. 
Hyperosmolar hyperglycaemic syndrome was not reported 
Cardiovascular risk 
The control of cardiovascular risk factors in populations with diabetes, particularly hypertension 
and hyperlipidemia, was addressed in six studies.24,40,41,45,52,53 Two studies compared hypertension 
control in cohorts of individuals with T2D pre- and post-conflict. In Yemen, BP control in the 
cohort with diabetes improved during the war.24 Likewise, in a cohort of fifty-five individuals with 
IDDM in Sarajevo, twenty-five individuals had BP readings >140/90 mmHg before the war and 
only twelve after the war (p<0.01).45  
Three studies were surveys of UNRWA programs for Palestine refugees with diabetes: The first 
was a survey of UNRWA health centers in 2011 and reported the presence of co-morbid 
hypertension in 68.5% of the population with diabetes. 55% had BP readings ≤140/90 mmHg and 
28.2% had readings ≤130/80 mmHg.52 Cholesterol levels were elevated >200 mg/dl in 39.8% of 
the population. Only 53.4% of patients with hyperlipidemia were on lipid lowering agents and 
most were making out-of-pocket payments. 
A second study with Palestine refugees in Amman, Jordan, reported 79% of the population had an 
associated diagnosis of hypertension, of which 63% had their BP measured and 75% had readings 
<140/90 mmHg.41 When evaluating the past 12-15 months, all patients with diabetes were reported 
to have had a total cholesterol level measured and of those, 72% had cholesterol levels <200 mg/dl.  
The third study evaluated cumulative and quarterly data on diabetes treatment outcomes from 
primary healthcare clinics across Jordan.40 They reported that 78% of patients returned for follow-
up within the last quarter with >99% having undergone BP and cholesterol measurements. Of 
these, 82% had BPs <140/90 mmHg and 71% had blood cholesterol levels <200 mg/dl. 
Among Syrian refugees with diabetes in a camp in Iraq, 9.1% of those with T1D and 55.4% of 
those with T2D were on antihypertensive agents (67.3% on ACE inhibitors).53 Among those with 
T1D, systolic and diastolic BP were controlled in 81.8% and 72.7% of patients, respectively. 
Among those with T2D, systolic BP was controlled in 54.9% and diastolic BP in 36.3% of patients. 
9.1% of refugees with T1D and 49.7% of those with T2D were treated with statins. However, in 
both groups cholesterol levels were not significantly different between those on and off statins.  
Health service utilization and access to care 
Ten studies reported health service utilization (the frequency and type of care consumed) and 
access to care,17,18,20-22,28-31,55 of which seven reported data on NCDs as a group (all included 
diabetes) and three studies reported data on diabetes separately.22,29,30 All were cross-sectional 
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household surveys conducted in the Eastern Mediterranean, which limits generalizability of the 
findings. Care-seeking behaviours, access to care, and health service utilization were generally not 
defined, making the results difficult to interpret. None of these studies reported data on health 
service utilization or access to care disaggregated by gender. Although healthcare service 
utilization was mostly reported for NCDs as a group, the results are described here since they 
include information on access to care for people with diabetes and the barriers to care for different 
NCDs are often similar.  
Care-seeking behaviours for those with self-reported NCDs who needed care were generally high 
among displaced populations in urban and camp settings in the Eastern Mediterranean (these were 
the only studies that included such data).20,21,30,31 Care was most commonly sought in primary 
healthcare facilities.20,21,29 One study reported that refugees with self-reported diabetes had the 
highest frequency of care-seeking among Syrian refugees with an NCD in Lebanon.29 Their results 
describe that 88.2% of Syrian refugees with diabetes had sought care since their arrival and 70% 
within the three months preceding the survey (of which 60.8% sought care in primary healthcare 
centres). Among displaced Yazidis in Iraq, 92.9% of those reporting an NCD diagnosis had seen 
a health provider for their condition during the three months preceding the survey.28 In Jordan and 
Syria, 85% of Iraqi refugees indicated that medical attention was sought the last time it was 
needed.31  
Despite high care-seeking behaviors, access to health services and medicines for NCDs appeared 
limited. Among Iraqi refugees with NCDs in Jordan and Syria who reported high care-seeking 
behaviors (>80%), only 62.5% of those in Jordan and 58.8% of those in Syria could get medical 
care when necessary.31 In Lebanon, 56.1% of Syrian refugees reported difficulty accessing care 
for NCDs.20 Among older Syrian refugees (>60 years of age) in Lebanon, of whom 47% reported 
having diabetes, nearly all surveyed reported the inability to obtain adequate medical treatment, 
primarily due to cost (3% reported having the resources to afford medications).55 
High costs due to out-of-pocket payments for consultation fees, medication prices, diagnostic tests, 
and transportation were the most common reason for not being able to access or continue care in 
all ten studies among all NCDs.17,18,20-22,30,31,55 The high costs were prohibitive to even seeking 
care for over half of Syrian refugees with diabetes in Jordan (51.7%).30 In Lebanon, 91.2% of 
Syrian refugees reported the expense of medical services being the greatest obstacle while seeking 
NCD care.21 In that study, 46.1% of those with chronic conditions reported treatment interruptions, 
primarily due to medication costs (89.3%), and 6% reported this was due to dangers in the area 
where medications were disbursed. Among Yazidis with NCDs displaced in Iraq who had reported 
high care-seeking behaviors, 40.0% were not taking prescribed medications, mainly citing the high 
costs.28 In Lebanon, 31.5% of Iraqi refugees with chronic conditions were not taking medications 
due to cost (78.9%) or lack of availability (10%).21  
Approximately 70% of all Syrian refugees in Lebanon paid out-of-pocket for consultant, 
diagnostic and laboratory fees.29 They noted that refugee spending on consultation fees was similar 
among the five NCDs assessed in the study, when measured by the proportion of patients with an 
out-of-pocket consultation payment.29 A UNHCR survey estimated the average monthly out-of-
pocket general health expenditure was USD$90 per household for Syrian refugees in Lebanon who 
needed care (the average monthly non-assisted household income was USD$173).20 Another 
survey reported a mean monthly expenditure on health for Iraqi refugees of USD$70 in Jordan and 
USD$91 in Syria.31 Most of the expenses were at outpatient and inpatient facilities for services 
and treatment (52.5%) and medicine and treatment supplies (29.0%). To cover these costs, 53.9% 
 7 
 
of Syrian refugees in Lebanon borrowed money, 39.4% used household income, and 27.8% relied 
on relatives or friends.20  
Aside from the cost of care, the unavailability of services was a barrier to care.17,21,22,35 In a study 
of Iraqi IDPs, the lack of medication at health facilities was cited as the most important barrier 
(23.7%).22 Only six papers in the literature review mentioned the types of diabetes medications 
that were prescribed and none reported on their availability.24,33,43,44,52,53 The next most common 
barrier to access was a lack of services available (18.4%). A report on Syrian refugees in Iraq cited 
the unavailability of services and the cost of care as the most common challenges of accessing 
healthcare.17 In two districts in Iraq, an estimated 6% of Syrian refugee households reported 
returning to Syria to seek healthcare.17  
KEY EVIDENCE GAPS AND NEXT STEPS FOR RESEARCH 
Our study demonstrates evidence assessing the burden of diabetes in humanitarian settings is very 
limited and of generally low quality. The levels of needs are not being adequately captured, 
particularly in crises beyond the Eastern Mediterranean. The following discussion reflects on the 
results of the review and proposes key research priorities based on these findings and our 
experience of working in and researching diabetes care in crisis-affected settings (summarized in 
Table 2). 
Burden of diabetes data 
Sampling techniques and outcome measures 
There are significant knowledge gaps of the epidemiology of diabetes in humanitarian settings, 
especially in Africa and South-East Asia. Most studies were conducted in conflict-affected 
populations in the Eastern Mediterranean, predominantly with refugees in host countries, rather 
than in areas of conflict. Thus, further research is needed within conflict-affected countries, 
particularly the acute phase of a crisis, and for natural disasters. 
Prevalence estimates were limited and difficult to interpret or generalize since nonprobability 
sampling techniques were frequently used.59 Most studies identified in the review did not report 
criteria used to diagnose or monitor diabetes. Fingerstick glucose and A1C measurements were 
not available or reported in most studies. Another weakness was reporting deaths due to diabetes, 
since most individuals die from complications of diabetes rather than acute exacerbations. 
Most cross-sectional surveys used self-reported medical diagnoses that were not verified by 
medical reports, which risks misdiagnoses and prevalence underestimations. For example, in a 
cross-sectional survey of Palestinian households in the West Bank and Gaza Strip that relied on 
self-report, 2.8% of adults had diabetes in the West Bank and 1.9% in the Gaza Strip.23 This 
contrasts with IDF estimated prevalence rates of 7.0% in Palestine.60 Among Syrian refugees in 
Lebanon, a household telephone survey with refugees reported a diabetes prevalence of 18%, 
whereas a cross-sectional cluster survey reported a prevalence of 9.9%.20,29 Despite these 
differences, multiple studies identified in this review reported diabetes as being one of the top three 
reasons for seeking care in Eastern Mediterranean countries.17-21,29 However, the value of this data 
for directing resources is questionable, given the lack of uniform standards for data collection. 
Diabetes phenotyping 
The evidence identified in the review failed to adequately capture the various phenotypes of 
diabetes. Across most studies retrieved from our search, diabetes was most often reported as a 
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single entity and distinctions between even the most common subtypes of diabetes (T1D, T2D, 
and GDM) were rarely mentioned. Making these distinctions is important in terms of triage, 
management decisions, and resource allocation. For example, in the acute phase of an emergency, 
identifying and prioritizing the care of individuals with T1D is crucial to minimize serious 
complications and death.  
Only two studies reported on the burden of GDM.21,35 However, global estimates from 2017 
suggest approximately 16% of total live births were affected by hyperglycemia in pregnancy, of 
which 88% were in LMICs.60 GDM increases the maternal risk of developing T2D later in life, is 
associated with serious adverse pregnancy outcomes, and carries the risk of transgenerational 
metabolic effects on the fetus which can be reduced through identification of GDM and glucose 
control in the mother.60 Considering the volume of obstetric and perinatal care in many 
humanitarian settings,6 screening and management of hyperglycemia in pregnancy needs to be 
integrated into routine perinatal care.  
Furthermore, atypical forms of diabetes have been emerging in recent decades. Ketosis-prone 
diabetes has become a recognized entity in populations mostly of African descent.61 These 
individuals are generally overweight or obese and present with ketoacidosis at diagnosis, but 
typically do not require long-term insulin therapy. There are also lean phenotypes of diabetes that 
are reported mostly in LMICs, such as malnutrition-modulated diabetes (MMDM) and 
fibrocalculous pancreatic diabetes.62,63 Individuals with these forms of diabetes are extremely lean 
and require high doses of insulin for good glycaemic control, however ketonuria rarely occurs. 
Jobanputra et al. recently reported that staff at an MSF-supported hospital in the Democratic 
Republic of Congo are managing both patients with T2D, as well as those with MMDM who have 
high insulin requirements and show signs of chronic complications early on.10 Thus, it is important 
to recognize that individuals with diabetes may not always present in a typical manner and we 
need to better characterize the epidemiology of diabetes in low-resource settings to identify 
individuals with diabetes, particularly in protracted crises, and allocate insulin to those who need 
it most. 
The dearth of baseline epidemiological data hinders appropriate needs-assessments and response-
planning which are essential to effectively meet the needs of crisis-affected populations. The 
development and standardization of epidemiologic tools and methods, particularly digital 
surveillance systems, are needed to more accurately capture the burden of diabetes (and other 
NCDs) and related health needs in crisis settings. 
Diabetes management and monitoring 
This review highlights the differences in treatment targets, standards of care, and monitoring for 
diabetes in humanitarian crises. Clinical guidance on the management and follow-up of diabetes 
in humanitarian settings is lacking and the knowledge-base on cost-effective models of care in 
such environments is very limited.9,10,13,14 Appropriate diagnostic cut-offs and glycaemic targets 
for diabetes care in humanitarian crises are unclear. This is particularly relevant in settings where 
individuals prescribed hypoglycaemic agents are exposed to significant food insecurity, home-
based glucose monitoring is unavailable and clinical follow-up is jeopardised due to insecurity. 
Moreover, optimum glucose testing methods, timing, and location in these settings are unknown.64 
It is also unclear how best to engage in secondary prevention and screening or treatment of diabetes 
complications in these settings. Importantly, data on monitoring and control of cardiovascular risk 
factors are lacking and need to be included in routine diabetes care, particularly in protracted crises. 
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Many of these challenges also affect populations in stable resource-poor settings. Therefore, 
examining diabetes care and outcomes in crisis-affected populations compared to those in equally 
resource-poor environments not affected by crisis may provide helpful insights into the unique 
challenges of each setting. 
Current guidelines, such as the Sphere standards (the most widely used guidance in humanitarian 
crises), provide very limited information on NCDs, including diabetes.65 The WHO Package of 
Essential Non-communicable Disease Interventions (PEN guidelines) provides practical resources 
and information on the delivery of diabetes in LMICs.66 Although these guidelines are often used 
in humanitarian crises, their effectiveness and appropriateness in such contexts have not been 
studied.  
The most detailed studies describing the practical management of diabetes in humanitarian crises 
were published by UNRWA.40,41,52 Screening methods, diagnostic criteria, medications, glycaemic 
and cardiovascular control parameters, complications and patient follow-up data were reported. 
Mobile phone technology was used to contact patients to ensure follow-up and medication 
adherence. Thus, there is scope to further explore the role of electronic medical records and mobile 
phone technology to support clinical decision-making, self-management and monitoring in 
humanitarian settings and develop basic health information systems to track chronic disease 
patients over time. While UNRWA services for Palestinian refugees are fairly unique in that they 
serve a very long-term and relatively static population and cannot be generalized to more acute 
crisis situations, they may provide useful guidance.   
Primary preventive and educational activities were not addressed in any of the publications 
retrieved by our search. Although these activities may not have priority in the acute phase of a 
humanitarian response, developing and testing cost-effective and sustainable individual or 
community-based models for promotion of self-care, adherence and health literacy would be 
valuable in protracted settings.  
To tackle these issues, a Working Group on NCD Control by UNHCR is developing an operational 
guidance document and a minimum set of NCD-specific indicators for the management and 
monitoring of NCDs across agencies. MSF has drafted and is field-piloting a clinical guideline for 
NCDs in crisis.  
Health service utilization and access to care 
Utilization of diabetes care and costs 
The results of the literature search described healthcare utilization patterns among displaced 
populations with diabetes in the Eastern Mediterranean (no reports were available in other global 
regions). Care seeking behaviors for individuals with diabetes and other NCDs were high overall. 
However, despite these high rates of healthcare seeking, access to care was significantly limited. 
The primary reason for this was the high cost of medications and healthcare services at outpatient 
and inpatient facilities, fees for diagnostic evaluations and transportation. Each study retrieved by 
our search that examined healthcare access and utilization among displaced populations found that 
high costs impeded access to care. Medical care in camps is provided by various actors, some may 
cover all costs, including medications, labs and referrals; others provide a minimum package or 
rely on unpredictable donations of medications. In non-camp settings, care is usually integrated 
within the public health system; services are more extensive, requiring co-payments for drugs, 
tests, and consultations. Thus, it is imperative to examine and implement cost-effective and 
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sustainable models of care to improve access to care and long-term outcomes. Studies are needed 
to document current patient, provider and health system costs and determine key cost drivers, 
which may be addressed through advocacy. Cost analyses would support humanitarian actors and 
host country systems in planning for the expensive tests and treatments, long disease duration, and 
specialist referral that may be involved in diabetes care. Since diabetes and its outcome are closely 
linked with co-morbidities, such as hypertension and hyperlipidaemia, cost-effective models of 
care need to be addressed together with other NCDs through integrated approaches. 
Continuity and integration of diabetes care 
Continuity of care is a major challenge in providing care to populations affected by crises.9,10 None 
of the studies retrieved by our search discussed ways of dealing with this in unstable settings. For 
example, how to ensure continuity of care when access or supplies are compromised due to 
insecurity or high population mobility. However, our search may not have captured these studies 
as it was limited to quantitative studies and these types of questions are generally explored through 
qualitative research.  
None of the studies described integrating diabetes or NCD care into host country health systems, 
as has been recommended.15 Since most displaced persons now live in urban areas, rather than in 
camps, coordinating and providing healthcare services for these populations is increasingly 
challenging.10,67 To ensure successful response planning and delivery, developing close 
relationships among humanitarian organizations and working with host country systems is 
important.68 Building local health system capacity in diabetes management by developing 
integrated NCD programmes, establishing referral pathways, and strengthening local supply 
chains, protocols and policies will support delivery of diabetes care to urban-based populations 
and promote sustainability post-crisis. Moreover, integrating NCD care into host country health 
services may be one way to address the challenge of financing healthcare in humanitarian crises, 
using the universal health insurance approach. 
NCD care has traditionally been provided in hospitals and by specialists in much of the Eastern 
Mediterranean, with little involvement of primary care.69 Decentralizing diabetes care to the 
primary care level would allow easier access to care and follow-up, although this may require a 
large cultural shift, even in stable environments. Additionally, given the success of HIV and TB 
programs using community health workers to deliver care in resource-constrained settings, it is 
important to examine and identify what routine tasks can be carried out by non-health professionals 
at the community level.10,67  For example, task-sharing of medication initiation and titration to 
nursing cadres, and health education and treatment support to community health workers, can be 
carried out at the primary care or community level. Moreover, considering the close link between 
diabetes and infectious diseases, integrating diabetes care into the routine practice of TB and/or 
HIV programs would likely be beneficial, allowing for the co-management of NCDs and infectious 
diseases which require long-term management and close surveillance.70,71 Developing and testing 
algorithm-driven, task-shared primary care models, building on HIV/TB care experiences, would 
facilitate diabetes care delivery in humanitarian crises. There is also a need to develop optimal 
context-adapted training and capacity-building models, for humanitarian workers and host country 
health system workers in diabetes and NCD care.  
Essential medicines and diagnostics 
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In many LMICs, the availability and continuous supply of essential medicines is limited for people 
with diabetes.72 The barriers to insulin use in LMICs include low insulin availability, high costs, 
and cold storage.73,74 These challenges are often magnified in humanitarian crises due to insecurity, 
interrupted healthcare systems, population mobility, and limited coordination between healthcare 
providers. Diabetes medications were rarely reported in the studies retrieved and none described 
the availability or supply of medications or diagnostic materials. Very little appears to be known 
about the accessibility and affordability of diabetes medications and related equipment in 
humanitarian crises. Documenting these access issues and developing context-specific solutions 
to improving access will be important. The use of insulin, and planning for it, in humanitarian 
crises is especially complicated for the contextual reasons given above. 
A positive development from WHO is its piloting a supplemental kit to the Interagency Emergency 
Health Kit which seeks to provide a temporary ration of medicines in humanitarian crises for a 
population of 10,000 persons for approximately three months.75 This kit includes metformin, 
sulfonylureas, insulin, urine and blood test strips.76 Since they are intended as temporary supplies, 
it is critical to build the capacity and resilience of local health systems to ensure the establishment 
of longer-term, robust medication supply chains.77 It is also essential to include a rapid training 
package to support humanitarian workers in its implementation.   
CONCLUSION 
Our review highlights that the burden of diabetes in humanitarian crises is poorly understood and 
so likely poorly addressed. Crisis-affected populations with diabetes face enormous constraints in 
accessing and receiving care, primarily due to the high costs of care. Further research is needed to 
develop standardized epidemiologic tools to better measure the burden and phenotypes of diabetes 
in crisis-affected populations, understand access and utilization patterns, develop guidelines and 
models of care, and evaluate their effectiveness and cost-effectiveness in meeting the needs of 
people living with diabetes in humanitarian crises. 
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Panel 1: Search strategy and selection criteria for literature review 
Eligibility: The population of interest was civilians (all ages) affected by complex humanitarian 
crises and natural disasters in LMICs, as defined by the World Bank.78,79 This included refugees 
and IDPs based upon standard definitions79,80 and those remaining in areas affected by crises. 
Refugees from LMICs living in high-income countries were excluded. The search was limited to 
LMICs since the majority of humanitarian crises occur in LMICs and the resources available to 
cope with them are different compared to those in high income countries. Humanitarian crises 
were defined as events stemming from armed conflicts, natural disasters, food insecurity and 
persecution that threaten the health and safety of a community.  The time periods of humanitarian 
crises included emergency (immediate aftermath of the event up to six months), protracted (crisis 
duration greater than six months), and early recovery time periods (more stable period of 
rebuilding up to two years following the crisis). For studies that include both crisis-affected and 
non-crisis affected populations, only studies that provided separate data for crisis and non-crisis 
affected populations were included. 
The primary outcome of interest was the burden of diabetes mellitus (all types) and its 
complications (including fatal and non-fatal events). The secondary outcomes of interest were 
healthcare services and access to care for individuals with diabetes. The initial literature search 
included all NCDs and from this initial literature search we included the studies that reported data 
on diabetes. Mental health was not included as it has already been reviewed elsewhere.81 Studies 
on organ failure arising from crushes (e.g. natural disasters) were excluded.  
Only quantitative studies using cross-sectional or cohort study designs (retrospective or 
prospective) reporting prevalence or incidence estimates were included. No date restrictions were 
used. Only papers in English were included. Both published and grey literature were included. 
Information Sources: We searched (with a search end date of October 30, 2017): Medline, 
Embase, IBSS, Web of Science, and Global Health.  Grey literature was sought through a 
combination of web-based searching of the main humanitarian databases and agency websites and 
contacting the main humanitarian agencies conducting such studies. The search fields were: (i) 
crisis-related terms; AND (ii) NCD terms; AND (iii) terms related to burden/prevalence/incidence.  
The full search sources, terms and syntax for the published literature are provided in Online Annex 
1.   
Study Selection and Data Extraction: Study selection involved a four-stage process: removal of 
duplicates (stage 1); screening by title (stage 2a) and abstract (stage 2b) and then full text (stage 
2c); grey literature screening and review of the reference lists of the final selected studies (stage 
3); and final review and analysis of the selected studies (stage 4). All data were double-screened 
and extracted by six authors (AC, DF, BR, JS, SK, RR) and any variances resolved between them.  
Analysis: Descriptive analysis was used given the heterogeneous nature of study context, 
population exposure, health outcomes, and study methodologies. Findings were organized by the 
three study objectives, and then into commonly recurring themes.  
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Table 1: Key study characteristics 
Study populations Refugees (N=25)17-21,25,26,29-31,33,35,39-43,47,48,50,52-55,57   
IDPs (N=5)22,28,32,46,56 
Other conflict-affected populations (N=11)23,24,27,34,36-38,44,45,49,51 
Affected by natural disasters (N=2)34,37 
Study location Eastern Mediterranean (N=30)17-24,28-33,39-44,46-48,50,52-57 
Europe (N=6)25,27,36,45,49,51 
Western Pacific (N=2)34,37 
South-East Asia (N=1)35 
Africa (N=1)38 
Multiple regions (N=1)26 
Study design Cross-sectional survey (N=37)17-26,28-35,38-44,46-57 
Retrospective cohort study (N=2)27,45 
Prospective cohort study (N=2)36,37 
Routine clinic/organizational data (N=14)26,32,38-44,47-49,51,57 
Outcome measure DM diagnostic criteria 
Self-reported diagnoses (N=12)20-23,25,28-31,36,46,55 
Fasting capillary glucose (N=5)40-43,54 
Random capillary glucose (N=1)50 
DM criteria not specified (N=15)17-19,26,27,32,37-39,44,47,48,51,56,57 
OGTT (N=1)35 
WHO diagnostic criteria (n=1)33 
ADA diagnostic criteria (n=1)24 
A1C (N=5)34,45,49,52,53 
DM Complications (N=5)30,40,41,52,53 
Glycaemic control (N=7)24,40,41,45,49,52,53 
Cardiovascular risk control (N=6)24,40,41,45,52,53 
Diabetes types T1D (N=10)27,33,40,41,47,49,51-53,57 
T2D (N=13)24,32,33,40,41,45-47,49,52-54,57 
GDM (N=2)22,35 
Type of DM not specified (N=24)17-21,23,25,26,28-31,34,36-39,42-44,48,50,55,56 
Barriers in health 
services access  
Cost (N=10)17,18,20-22,28-31,55 
Lack of available services (N=5)17,18,21,28,31  
Geography/did not know where to go (N=6)17,18,20,22,28,30,31,55 
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Table 2: Major research gaps and proposed next steps 
Knowledge Gaps Next Steps 
Burden of diabetes data 
Sampling techniques and outcome measures 
 Limited use of probabilistic sampling methods  
 Lack of uniform standards for data collection 
 Self-reported diagnoses not confirmed with 
biochemical measurement  
 Develop standardized epidemiologic tools and methods, 
using probabilistic sampling, to capture the burden of 
diabetes and other NCDs in crises 
 Confirmation of diabetes diagnoses, ideally using HbA1c 
point of care testing 
Diabetes phenotyping 
 Prevalence and characterisation of local DM 
epidemiology 
 Effective methods to rapidly identify known cases of 
DM and other NCDs in crises  
 Strengthen surveillance and health information systems in 
LMICs to improve baseline epidemiological data on DM  
 Adapt and test rapid assessment tools, which distinguish 
DM types 1 and 2, GDM (and other NCDs) to map needs, 
current services and to triage response in acute emergencies 
Diabetes management and monitoring 
 Evidence-based clinical guidance on diabetes 
management in crises 
 Optimum glucose testing method, timing and setting 
 Glycaemic targets which balance safety and 
effectiveness 
 Control of cardiovascular risk factors 
 Role of EMR and mHealth in clinical decision 
making, self-management and monitoring 
 Validated audit systems and indicators  
 
 Develop evidence-based clinical guidance on DM care and 
cardiovascular risk reduction in crises 
 Explore appropriate, safe and effective diagnostic cut-offs 
and treatment targets 
 Develop novel cost-effective technologies for standardized 
glucose and cardiovascular risk monitoring 
 Evaluate cost-effective community or facility-based models 
of DM care  
 Validate indicators and targets with a prospective study 
 Operational research to evaluate use of EMR/mHealth in 
clinical decision making, self-management and monitoring 
Health service utilization and access to care 
Utilization of diabetes care and costs 
 Utilization, access and coverage data for diabetes 
care in regions other than the Eastern Mediterranean 
 Access to and utilization of DM care in the acute 
phase of a crisis and in natural disasters. 
 Current patient, programmatic, and health system 
costs and cost-effective models of DM care in crises 
 Perform household utilisation and access surveys in regions 
other than the Eastern Mediterranean 
 Evaluate DM care delivery in the acute phase of a crisis and 
in natural disasters 
 Descriptive studies of costs of diabetes care in humanitarian 
settings from the patient and provider perspectives 
 Cost effective studies of models of care, which minimise 
patient direct and indirect costs 
Continuity and integration of diabetes care 
 Effective strategies to reduce treatment interruption 
in unstable settings  
 Evidence-based programmatic guidance on cost 
effective and sustainable integrated primary level 
delivery models including essential secondary 
prevention and referral systems 
 Cost-effectiveness of decentralised, algorithm-driven 
care model suited to task-sharing 
 Develop and test emergency preparedness plans, emergency 
packs and patient-held medical records 
 Develop and test an algorithm-driven care model, integrated 
with other NCDs, suited to task-sharing, with minimal 
clinical monitoring and complications screening Explore 
models of care which maximise continuity of care and 
integration between different health system levels, including 
secondary prevention screening 
Essential medicines and diagnostics 
 Current diabetes essential medications and 
diagnostics access, availability and affordability  
 Best practice and barriers re insulin use in 
humanitarian settings, including cold storage 
 Role of field-adapted POC tests/technology for 
diagnosis and monitoring DM and complications 
 Effective implementation and health worker training 
around use of Interagency Emergency Health Kit 
 Document diabetes essential medications and diagnostics 
access, availability and affordability in crisis settings and 
develop context- specific solutions, including around cold 
storage 
 Field test POC devices and testing algorithms 
 Explore novel approaches to identify and monitor DM 
complications  
 Evaluate Interagency Emergency Health Kit 
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